The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer
Honglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li · 2024
Read The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer by Honglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11618660.txt.
Description
Honglei Tao and co-authors report in 2024 that a pain drug mix may also fight lung cancer. Pain control is a core part of cancer care, but whether pain and numbing drugs help or harm tumors stays debated. The team screened sixteen common such drugs against non-small cell lung cancer cells.
One mix, butorphanol tartrate injection, stood out: it slowed cancer cell growth and made a drug-resistant cell line respond again to a standard targeted drug. Its main active part, benzethonium chloride, seems to act through a guard protein pathway that steers cell cycles and cell death. The find gives a base for pairing pain care with cancer care.
Catalog record
| CREATOR | Honglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |